Terminal › Stocks › ARKG

ARK Genomic Revolution ETF (ARKG) Stock

Financial Services · Asset Management · US

$50.06 +4.27%

Last updated Aug 25, 2026 20:24 UTC

ARKG Key Statistics

Market Cap$1.75B

P/E (TTM)—

P/S (TTM)—

P/B (TTM)—

Revenue (TTM)$0.00

EPS (TTM)—

Dividend Yield—

ROE (TTM)—

Net Margin—

Gross Margin—

52W High$49.56

52W Low$23.43

Analyst View—

Price Target—

Employees—

Volume5,705,993

About ARK Genomic Revolution ETF

The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity securities issued by both domestic and international companies. These companies are strategically chosen from various sectors based on their direct connection to the fund's core investment principle: the groundbreaking genomics revolution.

Company website

See ARKG live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open ARKG in Terminal See plans

More Financial Services stocks

MUFG Mitsubishi UFJ Financial Group, Inc. HDB HDFC Bank Limited CNCK Coincheck Group N.V. BRK-B Berkshire Hathaway Inc. JPM JPMorgan Chase & Co. BAC Bank of America Corporation C Citigroup Inc. RY Royal Bank of Canada